7Yigit H, Queenan AM, Anderson GJ,et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1 , from a carbapenem-resistantstrain of Klebsiella pneumoniae [ J ]. Antimicrob AgentsChemother,2001 ’45(4) :1151-1161.
8Wei ZQ,Du XX, Yu YS,et al. Plasmid-mediated KPC-2 in aKlebsiella pneumoniae isolate from China[ J]. Antimicrob AgentsChemother,2007 ,51(2):763-765.
9Kitchel B , Rasheed JK, Patel JB, et al. Molecular epidemiologyof KPC-producing Klebsiella pneumoniae isolates in the UnitedStates : clonal expansion of multilocus sequence type 258 [ J ].Antimicrob Agents Chemother,2009 ,53(8) :3365-3370.
10Centers for Disease Control and Prevention ( CDC) . Guidance forcontrol of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities [ J ]. MMWRMorb Mortal Wkly Rep, 2009,58 (10) :256-260.
5Yigit H,Queenan AM,Anderson GJ,et al.Novel carbapenem-hydrolyzing beta-lactamase,KPC-1,from a carbapenem-resistant strain of klebsiella pneumoniae[J].Antimicrob Agents Chemother,2001,45:1151-1161.
6Elhani D, Bakir L, Aouni M. The changing epidemiology of ex- tended spectrum 13-1actamase-producing Klebsiella pneumoniae. Ann Biol Clin (Paris) ,2011,69 ( 5 ) :523-529.
7Tofteland S, Haldorsen B, Dahl KH, et al. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta- lactamase-produeing clinical isolates of Escherichia coil and Kleb- siella pneumoniae in Norway. J Clin Microbiol, 2007,45 ( 1 ) : 199-205.
9Tzelepi E, Magana Ch, Platsouka E, et al. Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int J Antimicrob Agents, 2003,21( 3 ) :285 -288.
10Nasehi L, Shahcheraghi F, Nikbin VS, et al. PER, CTX-M, TEM and SHV Beta- lactamases in clinical isolates of Klebsiella pneumoniae isolated from Tehran, Iran. Iran J Basic Med Sci, 2010,13(3) :111-118.
5Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing:22th in- formational supplement,M100-S22[S].2012.
6Pappo-wallacekm,Endimiania,Taracila MA,et al.Cara- penems:Past,present and future[J].Antimcrob Agents Chemo-therapy,2011,55(11):4943-4960.
7MacKenzie FM,Forbes KJ,Dorai-John T,et al.Emer- gence of a carbapenem-resistant Klebsiella pneumoniae[J].Lancet,1997,350(9080):783.
8Arnold RS,Them KA,Sharma S,et al.Emergence of Kleb- siella pneumoniae carbapenemase-producing bacteria[J].South Med J,2011,104(1):4045.
9ChangHJ, Hsu PC, Yang CC, et al. Riskfactom and outcomes of earbapenem - nonsusceptible Escherichia coli bacteremia: A mat- ched case - control study[ J]. J Micmbiol Immunol Infect, 2011, 42(2) : 125 -130.
10Maiden MC. Muhilocus sequence typing of bacteria[ J]. Annu Rev Microbiol, 2006, 60 (12) : 561 - 588.
